US Stock MarketDetailed Quotes
ABVX Abivax S.A.
- 10.270
- -0.050-0.48%
Close Nov 1 16:00 ET
- 10.400
- +0.130+1.27%
Post 16:01 ET
646.05MMarket Cap-2751P/E (TTM)
10.400High10.210Low259.22KVolume10.360Open10.320Pre Close2.69MTurnover1.00%Turnover RatioLossP/E (Static)62.91MShares17.02052wk High3.03P/B266.23MFloat Cap8.75052wk Low--Dividend TTM25.92MShs Float17.020Historical High--Div YieldTTM1.84%Amplitude7.995Historical Low10.388Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Abivax S.A. Stock Forum
Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model
Abivax has announced initial preclinical combination data of obefazimod and etrasimod in an inflammatory bowel disease (IBD) mouse model. The company is conducting studies with multiple oral and injectable therapies, with additional data expected in Q4 2024. The p...
No comment yet